EP-104IAR (Long-Acting Intra-Articular Injection of Fluticasone Propionate) Shows Sustained Improvement in Pain for Subjects with Moderate Baseline Pain and BMI Less Than 30 in SPRINGBOARD, a Phase 2, Randomized, 24-Week Study of Osteoarthritis of the Knee

被引：0

作者：

Malone, Amanda ^{[1
]}

Helliwell, James ^{[1
]}

Kowalski, Mark ^{[1
]}

Rovsing, Helene ^{[2
]}

Boll, Sidsel Lynggaard ^{[3
]}

Bihlet, Asger Reinstrup ^{[4
]}

Miller, Claire Prener ^{[5
]}

Mondragon, Alejandro Castillo ^{[4
]}

Li, Yanqi ^{[4
]}

Dobek, Christine ^{[1
]}

Peck, Vik ^{[1
]}

Dye, Andrew ^{[1
]}

Wilmink, Mike ^{[6
]}

Simon, Lee ^{[7
]}

Conaghan, Philip G. ^{[8
,9
]}

机构：

[1] Eupraxia Pharmaceut, Victoria, BC, Canada

[2] NBCD A S, Nordjylland, Denmark

[3] NBCD A S, Syddanmark, Denmark

[4] NBCD A S, Soborg, Denmark

[5] Novo Nordisk A S, Bagsvaerd, Denmark

[6] OrthoArizona, Phoenix, AZ USA

[7] SDG LLC, W Newton, MA USA

[8] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, England

[9] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, England

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2106

引用

页码：4257 / 4259

页数：3

共 3 条